RESEARCHER PROFILE
Jason Rogers (Filmed April 2024)
Postdoctoral Fellow
Menzies Institute for Medical Research,
University of Tasmania
Jason Rogers is a Tasmanian physiotherapist clinician-researcher with a longstanding interest in improving musculoskeletal foot and ankle conditions. He completed his PhD at the Menzies Institute for Medical Research at the University of Tasmania in 2022 investigating the clinical and imaging factors associated with a common foot complaint known as chronic plantar heel pain.
Chronic plantar heel pain, historically known as plantar fasciitis, is common and commonly recalcitrant, yet the optimal treatment for this condition is not clear. The focus of Jason’s postgraduate research is on improving treatment pathways for chronic plantar heel pain. In particular his research has identified that there are many different sub-groups of plantar heel pain that may warrant specific and individualised treatment approaches. For example his research found that up to half of people with this condition have a type of bone bruise or stress response in the heel known as a ‘bone marrow lesion’ (BML). His BALSA trial will test the effectiveness of targeting these lesions with a bone-sensitive treatment known as shockwave therapy, comparing pain and BML size outcomes against a sham shockwave control group.
As well as improving treatment outcomes for this specific and sizeable sub-group of heel pain sufferers, this research will help inform the future of targeted care treatment approaches for plantar heel pain.
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
-
Role of metabolic dysfunction in advanced prostate cancer
Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.
-
CASE STUDY Role of Exercise in Metabolic Associated Fatty Liver Disease
Dr. Shelley Keating AES AEP* is an Accredited Exercise Physiologist, a researcher, and a senior lecturer at the School of Human Movement and Nutrition Sciences at the University of Queensland in Brisbane, Australia. Dr. Keating’s research primarily focuses on the role of exercise in the management of metabolic dysfunction associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. MASLD affects a significant portion of the global adult population, with many individuals unaware of their condition.
